Psoriasiform lesions as a side effect of SGLT-2 therapy

• Váldodahkkit: Jakub Krzysztof Gałązka (Dahkki), Łukasz Domagalski (Dahkki), Piotr Homa (Dahkki), Zofia Hoffman (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: Nicolaus Copernicus University in Toruń, 2023-01-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

SGLT-2 inhibitors (flozins) are one of the new classes of anti-diabetic drugs, used from 2012. They are highly recommended in case of intolerance or contraindication of metformin, but in Poland they are used usually as third-line drug after metformin and sulfonylurea. They growing popularity is caus...